American Cancer Society http://www.cancer.org
National Cancer Institute http://www.cancer.gov
Canadian Cancer Society http://cancer.ca
Canadian Breast Cancer Foundation http://www.cbcf.org
Gianni L, Dafni U, Gelber RD, et al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Lancet Oncol. 2011;12(3):236-244.
HER2 inhibitors for breast cancer. EBSCO DynaMed Plus website. Available at:
https://www.dynamed.com/topics/dmp~AN~T901191/HER2-inhibitors-for-breast-cancer. Updated January 12, 2015. Accessed October 24, 2016.
Herceptin. Daily Med website. Available at:
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2. Updated March 22, 2016. Accessed October 24, 2016.
Hortobagyi GN. Trastuzumab in the treatment of breast cancer.
N Engl J Med.
Piccart-Gebhart MJ, Procter M, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
N Engl J Med. 2005;353(16):1659-1672.
Romond EH, Perez EA, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
N Engl J Med.
Slamon DJ, Leyland-Jones B, et al. Concurrent administration of anti-HER2 monoclonal antibody and first-line chemotherapy for HER2-overexpressing metastatic breast cancer: A phase III, multinational, randomized, controlled trial.
N Engl J Med.
Smith I, Procter M, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Trastuzumab. EBSCO DynaMed Plus website. Available at:
https://www.dynamed.com/topics/dmp~AN~T233586/Trastuzumab. Updated October 25, 2016. Accessed November 2, 2016.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.